- Home
- HOWL vs AIXI Comparison
HOWL vs AIXI Comparison
Compare HOWL & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- AIXI
- Stock Information
- Founded
- HOWL 2017
- AIXI 2001
- Country
- HOWL United States
- AIXI China
- Employees
- HOWL N/A
- AIXI N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- AIXI Computer Software: Prepackaged Software
- Sector
- HOWL Health Care
- AIXI Technology
- Exchange
- HOWL Nasdaq
- AIXI Nasdaq
- Market Cap
- HOWL 37.9M
- AIXI 35.9M
- IPO Year
- HOWL 2021
- AIXI 2023
- Fundamental
- Price
- HOWL $0.87
- AIXI $3.75
- Analyst Decision
- HOWL Strong Buy
- AIXI
- Analyst Count
- HOWL 3
- AIXI 0
- Target Price
- HOWL $9.00
- AIXI N/A
- AVG Volume (30 Days)
- HOWL 232.7K
- AIXI 87.8K
- Earning Date
- HOWL 05-08-2025
- AIXI 05-20-2025
- Dividend Yield
- HOWL N/A
- AIXI N/A
- EPS Growth
- HOWL N/A
- AIXI N/A
- EPS
- HOWL N/A
- AIXI N/A
- Revenue
- HOWL $1,143,000.00
- AIXI $65,643,604.00
- Revenue This Year
- HOWL N/A
- AIXI $22.85
- Revenue Next Year
- HOWL $733.33
- AIXI $22.70
- P/E Ratio
- HOWL N/A
- AIXI N/A
- Revenue Growth
- HOWL N/A
- AIXI 6.22
- 52 Week Low
- HOWL $0.60
- AIXI $2.06
- 52 Week High
- HOWL $6.34
- AIXI $13.05
- Technical
- Relative Strength Index (RSI)
- HOWL 46.85
- AIXI 54.42
- Support Level
- HOWL $0.80
- AIXI $3.23
- Resistance Level
- HOWL $0.97
- AIXI $3.85
- Average True Range (ATR)
- HOWL 0.07
- AIXI 0.44
- MACD
- HOWL 0.02
- AIXI 0.08
- Stochastic Oscillator
- HOWL 41.92
- AIXI 78.05
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.